Status and phase
Conditions
Treatments
About
HIP2B is being developed for the treatment of type 1 and type 2 diabetes mellitus.
The purpose of this study is to investigate the safety and tolerability of repeat doses of HIP2B in subjects with type 2 diabetes mellitus. The study will also assess whether islet β-cell number and function will increase over time in response to repeat HIP2B injections.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adults aged 30 to 65 years, inclusive
Males and females
Diagnosis of type 2 diabetes mellitus prior to screening meeting the following criteria:
Ability to provide written informed consent and be willing to comply with scheduled visits, treatment plan, laboratory tests and other study procedures
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
32 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal